225 related articles for article (PubMed ID: 24960223)
1. Directed polyvalent display of sulfated ligands on virus nanoparticles elicits heparin-like anticoagulant activity.
Mead G; Hiley M; Ng T; Fihn C; Hong K; Groner M; Miner W; Drugan D; Hollingsworth W; Udit AK
Bioconjug Chem; 2014 Aug; 25(8):1444-52. PubMed ID: 24960223
[TBL] [Abstract][Full Text] [Related]
2. Bio-layer interferometry of a multivalent sulfated virus nanoparticle with heparin-like anticoagulant activity.
Groner M; Ng T; Wang W; Udit AK
Anal Bioanal Chem; 2015 Jul; 407(19):5843-7. PubMed ID: 25957844
[TBL] [Abstract][Full Text] [Related]
3. Heparin Binding to an Engineered Virus-like Nanoparticle Antagonist.
Cheong HY; Groner M; Hong K; Lynch B; Hollingsworth WR; Polonskaya Z; Rhee JK; Baksh MM; Finn MG; Gale AJ; Udit AK
Biomacromolecules; 2017 Dec; 18(12):4113-4120. PubMed ID: 28949131
[TBL] [Abstract][Full Text] [Related]
4. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of Fucosylated Chondroitin Sulfate Glycoclusters: A Robust Route to New Anticoagulant Agents.
Zhang X; Yao W; Xu X; Sun H; Zhao J; Meng X; Wu M; Li Z
Chemistry; 2018 Feb; 24(7):1694-1700. PubMed ID: 29131431
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and anticoagulant activity in vitro of heparin-like 6-carboxylchitin derivative.
Yang J; Cai J; Wu K; Li D; Hu Y; Li G; Du Y
Int J Biol Macromol; 2012 May; 50(4):1158-64. PubMed ID: 22266383
[TBL] [Abstract][Full Text] [Related]
7. Polyvalent Hybrid Virus-Like Nanoparticles with Displayed Heparin Antagonist Peptides.
Choi JM; Bourassa V; Hong K; Shoga M; Lim EY; Park A; Apaydin K; Udit AK
Mol Pharm; 2018 Aug; 15(8):2997-3004. PubMed ID: 29902009
[TBL] [Abstract][Full Text] [Related]
8. Heparin antagonism by polyvalent display of cationic motifs on virus-like particles.
Udit AK; Everett C; Gale AJ; Reiber Kyle J; Ozkan M; Finn MG
Chembiochem; 2009 Feb; 10(3):503-10. PubMed ID: 19156786
[TBL] [Abstract][Full Text] [Related]
9. Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.
Gale AJ; Elias DJ; Averell PM; Teirstein PS; Buck M; Brown SD; Polonskaya Z; Udit AK; Finn MG
Thromb Res; 2011 Oct; 128(4):e9-13. PubMed ID: 21496885
[TBL] [Abstract][Full Text] [Related]
10. A novel glycosaminoglycan-like polysaccharide from abalone Haliotis discus hannai Ino: purification, structure identification and anticoagulant activity.
Li G; Chen S; Wang Y; Xue Y; Chang Y; Li Z; Wang J; Xue C
Int J Biol Macromol; 2011 Dec; 49(5):1160-6. PubMed ID: 21968010
[TBL] [Abstract][Full Text] [Related]
11. Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.
Pokorski JK; Hovlid ML; Finn MG
Chembiochem; 2011 Nov; 12(16):2441-7. PubMed ID: 21956837
[TBL] [Abstract][Full Text] [Related]
12. Chemoselective modification of turnip yellow mosaic virus by Cu(I) catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction and its application in cell binding.
Zeng Q; Saha S; Lee LA; Barnhill H; Oxsher J; Dreher T; Wang Q
Bioconjug Chem; 2011 Jan; 22(1):58-66. PubMed ID: 21166476
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulant activity of a sulfated Lachnum polysaccharide in mice with a state of hypercoagulability.
Du Z; Shi F; Liu D; Ye H; Surhio MM; Li J; Ye M
Bioorg Med Chem Lett; 2016 Nov; 26(22):5550-5556. PubMed ID: 27769624
[TBL] [Abstract][Full Text] [Related]
14. Structure and anticoagulant activity of fucosylated glycosaminoglycan degraded by deaminative cleavage.
Zhao L; Lai S; Huang R; Wu M; Gao N; Xu L; Qin H; Peng W; Zhao J
Carbohydr Polym; 2013 Nov; 98(2):1514-23. PubMed ID: 24053834
[TBL] [Abstract][Full Text] [Related]
15. Sulfation of fucogalactan from Agaricus bisporus: Different patterns in the chemical structure and their effects on anticoagulant activity.
Román Ochoa Y; Iacomini M; Sassaki GL; Cipriani TR
Int J Biol Macromol; 2017 Apr; 97():357-364. PubMed ID: 28082227
[TBL] [Abstract][Full Text] [Related]
16. Regioselective sulfation of β-glucan from Ganoderma lucidum and structure-anticoagulant activity relationship of sulfated derivatives.
Zhang Z; Tang Q; Wu D; Zhou S; Yang Y; Feng N; Tang C; Wang J; Yan M; Liu Y; Zhang J
Int J Biol Macromol; 2020 Jul; 155():470-478. PubMed ID: 32240743
[TBL] [Abstract][Full Text] [Related]
17. Pyridine-phosphinimine ligand-accelerated Cu(I)-catalyzed azide-alkyne cycloaddition for preparation of 1-(pyridin-2-yl)-1,2,3-triazole derivatives.
Sun R; Wang H; Hu J; Zhao J; Zhang H
Org Biomol Chem; 2014 Aug; 12(31):5954-63. PubMed ID: 24984611
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
Han F; Yao W; Yang X; Liu X; Gao X
Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
[TBL] [Abstract][Full Text] [Related]
19. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant activity of a sulfated chitosan.
Vongchan P; Sajomsang W; Subyen D; Kongtawelert P
Carbohydr Res; 2002 Jul; 337(13):1239-42. PubMed ID: 12110200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
